Legal Representation
Attorney
Mary M. Cheli
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 11, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 10, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 12, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 11, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 11, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 1, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 1, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 20, 2010 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 7, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 13, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 13, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 7, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 7, 2010 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 7, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 7, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 7, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 7, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 28, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 30, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "REMINSET" has no meaning in a foreign language.
Classification
International Classes
005